STOCK TITAN

[Form 4] Sera Prognostics, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Mirza Mansoor Raza, a director of Sera Prognostics, Inc. (SERA), reported a non-discretionary sale of 222 shares of Class A common stock on 09/05/2025 to satisfy tax withholding from vested restricted stock units. The shares were sold via a mandated "sell-to-cover" process at a weighted average price of $3.35 (transactions ranged $3.35–$3.36). After the transaction the reporting person beneficially owned 58,480 shares. The Form 4 was filed by one reporting person and signed by an attorney-in-fact.

Mirza Mansoor Raza, amministratore di Sera Prognostics, Inc. (SERA), ha effettuato una vendita non discrezionale di 222 azioni di azioni ordinarie di Classe A il 09/05/2025 per coprire la ritenuta fiscale su restricted stock units maturate. Le azioni sono state vendute tramite la procedura obbligatoria "sell-to-cover" a un prezzo medio ponderato di $3.35 (transazioni tra $3.35 e $3.36). Dopo l’operazione, la persona segnalante deteneva beneficiariamente 58.480 azioni. Il Modulo 4 è stato depositato da un unico dichiarante e firmato da un procuratore.

Mirza Mansoor Raza, director de Sera Prognostics, Inc. (SERA), comunicó una venta no discrecional de 222 acciones de acciones ordinarias Clase A el 09/05/2025 para cubrir la retención fiscal correspondiente a unidades restringidas de acciones que se consolidaron. Las acciones se vendieron mediante un proceso obligatorio de "sell-to-cover" a un precio medio ponderado de $3.35 (operaciones entre $3.35 y $3.36). Tras la transacción, la persona informante poseía de forma beneficiosa 58.480 acciones. El Formulario 4 fue presentado por una sola persona informante y firmado por un apoderado.

Mirza Mansoor Raza는 Sera Prognostics, Inc.(SERA)의 이사로서, 2025-09-05에 확정된 제한주식(RSU)의 세금 원천징수를 충당하기 위해 222주의 클래스 A 보통주를 비재량식으로 매도했다고 보고했습니다. 해당 주식은 의무적인 "sell-to-cover" 방식으로 가중평균 가격 $3.35(거래 범위 $3.35–$3.36)에 매각되었습니다. 거래 후 보고인은 실질적으로 58,480주를 보유하고 있었습니다. Form 4는 한 명의 보고인이 제출했으며 대리인이 서명했습니다.

Mirza Mansoor Raza, administrateur de Sera Prognostics, Inc. (SERA), a déclaré une vente non discrétionnaire de 222 actions ordinaires de classe A le 09/05/2025 afin de couvrir la retenue fiscale liée à des restricted stock units acquises. Les actions ont été vendues via le processus obligatoire « sell-to-cover » à un prix moyen pondéré de 3,35 $ (transactions entre 3,35 $ et 3,36 $). Après l’opération, la personne déclarée détenait à titre bénéficiaire 58 480 actions. Le Formulaire 4 a été déposé par un seul déclarant et signé par un mandataire.

Mirza Mansoor Raza, Direktor von Sera Prognostics, Inc. (SERA), meldete am 09/05/2025 einen nicht-diskretionären Verkauf von 222 Anteilen der Klasse-A-Stammaktien zur Begleichung der Lohnsteuerabzüge für ausgeübte Restricted Stock Units. Die Aktien wurden im verpflichtenden "sell-to-cover"-Verfahren zu einem gewichteten Durchschnittspreis von $3.35 (Transaktionen zwischen $3.35 und $3.36) verkauft. Nach der Transaktion besaß die meldende Person wirtschaftlich 58.480 Aktien. Das Formular 4 wurde von einer meldenden Person eingereicht und von einem Bevollmächtigten unterzeichnet.

Positive
  • None.
Negative
  • None.

Insights

TL;DR Routine sell-to-cover reduced holdings slightly; no voluntary disposition or material change to ownership stake.

The filing documents a standard tax-withholding sale tied to RSU vesting rather than an intentional trade by the director. The number sold, 222 shares, and the post-transaction beneficial ownership of 58,480 shares suggest this is an administrative transaction with limited market or governance impact. Prices reported are a weighted average of $3.35 with individual trades between $3.35 and $3.36.

TL;DR Disclosure aligns with Section 16 requirements; transaction appears compliant and non-material.

The report clearly states the sale was mandated by the issuer's sell-to-cover election for RSU tax withholding, which preserves Rule 10b5-1 affirmative defense context and transparency obligations. Reporting by a single person and signature by an attorney-in-fact meet filing protocols. No additional governance concerns are disclosed in this Form 4.

Mirza Mansoor Raza, amministratore di Sera Prognostics, Inc. (SERA), ha effettuato una vendita non discrezionale di 222 azioni di azioni ordinarie di Classe A il 09/05/2025 per coprire la ritenuta fiscale su restricted stock units maturate. Le azioni sono state vendute tramite la procedura obbligatoria "sell-to-cover" a un prezzo medio ponderato di $3.35 (transazioni tra $3.35 e $3.36). Dopo l’operazione, la persona segnalante deteneva beneficiariamente 58.480 azioni. Il Modulo 4 è stato depositato da un unico dichiarante e firmato da un procuratore.

Mirza Mansoor Raza, director de Sera Prognostics, Inc. (SERA), comunicó una venta no discrecional de 222 acciones de acciones ordinarias Clase A el 09/05/2025 para cubrir la retención fiscal correspondiente a unidades restringidas de acciones que se consolidaron. Las acciones se vendieron mediante un proceso obligatorio de "sell-to-cover" a un precio medio ponderado de $3.35 (operaciones entre $3.35 y $3.36). Tras la transacción, la persona informante poseía de forma beneficiosa 58.480 acciones. El Formulario 4 fue presentado por una sola persona informante y firmado por un apoderado.

Mirza Mansoor Raza는 Sera Prognostics, Inc.(SERA)의 이사로서, 2025-09-05에 확정된 제한주식(RSU)의 세금 원천징수를 충당하기 위해 222주의 클래스 A 보통주를 비재량식으로 매도했다고 보고했습니다. 해당 주식은 의무적인 "sell-to-cover" 방식으로 가중평균 가격 $3.35(거래 범위 $3.35–$3.36)에 매각되었습니다. 거래 후 보고인은 실질적으로 58,480주를 보유하고 있었습니다. Form 4는 한 명의 보고인이 제출했으며 대리인이 서명했습니다.

Mirza Mansoor Raza, administrateur de Sera Prognostics, Inc. (SERA), a déclaré une vente non discrétionnaire de 222 actions ordinaires de classe A le 09/05/2025 afin de couvrir la retenue fiscale liée à des restricted stock units acquises. Les actions ont été vendues via le processus obligatoire « sell-to-cover » à un prix moyen pondéré de 3,35 $ (transactions entre 3,35 $ et 3,36 $). Après l’opération, la personne déclarée détenait à titre bénéficiaire 58 480 actions. Le Formulaire 4 a été déposé par un seul déclarant et signé par un mandataire.

Mirza Mansoor Raza, Direktor von Sera Prognostics, Inc. (SERA), meldete am 09/05/2025 einen nicht-diskretionären Verkauf von 222 Anteilen der Klasse-A-Stammaktien zur Begleichung der Lohnsteuerabzüge für ausgeübte Restricted Stock Units. Die Aktien wurden im verpflichtenden "sell-to-cover"-Verfahren zu einem gewichteten Durchschnittspreis von $3.35 (Transaktionen zwischen $3.35 und $3.36) verkauft. Nach der Transaktion besaß die meldende Person wirtschaftlich 58.480 Aktien. Das Formular 4 wurde von einer meldenden Person eingereicht und von einem Bevollmächtigten unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mirza Mansoor Raza

(Last) (First) (Middle)
C/O SERA PROGNOSTICS, INC.
2749 EAST PARLEYS WAY, SUITE 200

(Street)
SALT LAKE CITY UT 84109

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SERA PROGNOSTICS, INC. [ SERA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/05/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 09/05/2025 S 222(1) D $3.35(2) 58,480 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person.
2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.35 to $3.36, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
/s/ Benjamin G. Jackson, Attorney-in-fact 09/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Mirza Mansoor Raza report on Form 4 for SERA?

He reported a sale of 222 shares of Class A common stock on 09/05/2025 to cover tax withholding from vested RSUs.

At what price were the SERA shares sold in the Form 4 transaction?

The weighted average price reported was $3.35; individual sale prices ranged from $3.35 to $3.36.

How many SERA shares does the reporting person own after the reported sale?

The reporting person beneficially owned 58,480 shares following the transaction.

Was the sale in the Form 4 discretionary or mandated?

The sale was mandated by the issuer's sell-to-cover election to satisfy tax withholding and was not a discretionary trade by the reporting person.

Who signed the Form 4 filing for this transaction?

The Form 4 was signed by Benjamin G. Jackson, Attorney-in-fact on 09/05/2025.
Sera Prognostics, Inc.

NASDAQ:SERA

SERA Rankings

SERA Latest News

SERA Latest SEC Filings

SERA Stock Data

129.79M
32.85M
10.87%
64.98%
3.27%
Medical Devices
Services-medical Laboratories
Link
United States
SALT LAKE CITY